http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014080051-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f11ac5ada799060f8c2e97b1ee47b80d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-06
filingDate 2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4914a8b5768e10fa118a51e9705f40bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba20a6055951921d07b52de869cb500c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa67d1623eb91cbc617a067eed79302f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fb3e55e7943a359c010d9422de6546a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98eb8197fe24b25c25e9d06543a57492
publicationDate 2014-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014080051-A1
titleOfInvention Use of l-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars
abstract The invention relates to the use of L-carnitine or its salts and derivatives in dermatological cosmetic products, preferably within the technical field associated with the cosmetic treatment of all types of superficial scars and stretch marks on mammals, preferably humans, as a result of the antifibrotic effect of carnitine.
priorityDate 2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007043339-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008206290-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2251126-T3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012089105-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288

Total number of triples: 47.